# CLABSI Prevention With Tissue Adhesive

> **NCT05721677** · NA · RECRUITING · sponsor: **Rabin Medical Center** · enrollment: 600 (estimated)

## Conditions studied

- Central-line Associated Blood Stream Infections (CLABSI)

## Interventions

- **DEVICE:** 2-octyl cyanoacrylate based topical skin adhesive

## Key facts

- **NCT ID:** NCT05721677
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-15
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-09-15
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05721677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05721677, "CLABSI Prevention With Tissue Adhesive". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05721677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*